Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

mPhase Technologies, Inc. Continues to Position Scalable Smart Reserve Cell Technology for 2011 Federal Funding

Published: Tuesday, January 04, 2011
Last Updated: Tuesday, January 04, 2011
Bookmark and Share
The company is to recommence active efforts in January of 2011 to secure federal funding for its scalable smart reserve cell technology, one of the line items included in the Fiscal Year 2011 Defense Appropriations bill that was passed in the United States House of Representatives.

Scalable Smart Reserve Cell Technology was listed to receive funding as part of the omnibus appropriations bill that failed to achieve a bipartisan compromise in the United States Senate in December of 2010, as part of the budget for the current 2011 fiscal year. Nevertheless, the Company is actively seeking to have such line item funding reintroduced in January of 2011, as part of early consideration in a defense appropriations bill for the 2011 fiscal year, and it is anticipated that it should be a high-priority item for the next Congress to augment to the temporary resolution that is currently funding the U.S. government.

"We are encouraged that the prior Congress has recognized the importance of this technology," said Mr. Ronald Durando, mPhase's President and Chief Executive Officer. The bill that was passed by the House of Representative in the last Congressional session is the first time Congress specifically designated funding for this type of technology. The Company continues to believe that it will be well positioned for a defense appropriations line item in the next Congress that convenes in January of 2011, given the company's leadership in the field.

The company is a leader in developing new innovative products using micro fluid dynamics, MEMS and super-hydrophobic suspension and separation of liquids on micro structures of silicon, developed through the science of nanotechnology. mPhase began using nanotechnology to develop power cells in 2004 with the Bell Labs division of Alcatel-Lucent (formerly Lucent Technologies, Inc.)

The Company has successfully delivered to the United States Army under a Phase II STTR grant a prototype of its Smart NanoBattery. "We believe that the successful delivery of a prototype of a first of its kind reserve battery designed for backup power for critical mission computer memory is vital in strategic weapons systems and sensor networks," said Durando. The company is positioned to custom tailor its Smart NanoBattery for a variety of military subsystems and critical mission commercial products. The Company is in the process of applying for new Phase I grants under both STTR and SBIR programs promulgated by the United States Department of Defense and the United States Department of Energy, as well as National Science Foundation grants.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

mPhase Announces Letter of Intent to Acquire Energy Innovative Products, Inc.
EIP uses patented and patent pending solutions to offer a series of products that control voltage and current used by compressor systems.
Wednesday, August 03, 2011
mPhase Technologies Signs 3 Year CRADA With US Army
The agreement continue to cooperatively test and evaluate the mPhase Smart NanoBattery, including new design features and functionally appropriate for DoD based systems requiring portable power sources.
Monday, February 14, 2011
Scientific News
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!